Literature DB >> 8384443

Mechanisms of elevation of adenosine levels in anoxic hepatocytes.

F Bontemps1, M F Vincent, G Van den Berghe.   

Abstract

Previous work has shown that normoxic isolated rat hepatocytes continuously produce adenosine from AMP and that the nucleoside is not catabolized further but immediately rephosphorylated by adenosine kinase [Bontemps, Van den Berghe and Hers (1983) Proc. Natl. Acad. Sci. U.S.A. 80, 2829-2833]. We now report the effect of anoxia on adenosine production and on the AMP/adenosine substrate cycle. In cell suspensions incubated in O2/CO2, the adenosine concentration was about 0.4 microM. It increased 30-fold in cells incubated in N2/CO2 or with 5 mM KCN, and 20-fold in cells incubated with 2 mM amytal. Adenosine production, measured in hepatocytes in which adenosine kinase and adenosine deaminase were inhibited by 5-iodotubercidin and deoxycoformycin respectively, was about 18 nmol/min per g of cells in normoxia; it increased about 2-fold in anoxia, although AMP increased 8-16-fold in this condition. From studies with inhibitors of membrane 5'-nucleotidase and of S-adenosylhomocysteine hydrolase, it was deduced that adenosine is produced by the latter enzyme and by cytosolic 5'-nucleotidase in normoxia, and by cytosolic and membrane 5'-nucleotidases in anoxia. Unlike in normoxic hepatocytes, inhibition of adenosine kinase by 5-iodotubercidin neither elevated the adenosine concentration nor enhanced total purine release from adenine nucleotides in cells treated with N2/CO2 or KCN; it had only a slight effect in cells treated with amytal. This indicates that recycling of adenosine is suppressed or profoundly inhibited in anoxia. The rate of accumulation of adenosine in anoxia was several-fold lower than the rate of its rephosphorylation upon reoxygenation. It is concluded that the elevation of adenosine in anoxic hepatocytes is much more dependent on decreased recycling of adenosine by adenosine kinase than on increased production by dephosphorylation of AMP.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384443      PMCID: PMC1132333          DOI: 10.1042/bj2900671

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  44 in total

1.  Extracellular metabolites in suspensions of isolated hepatocytes.

Authors:  E Van Schaftingen; L Hue; H G Hers
Journal:  Biochem J       Date:  1987-12-01       Impact factor: 3.857

Review 2.  The role of adenosine in the regulation of coronary blood flow.

Authors:  R M Berne
Journal:  Circ Res       Date:  1980-12       Impact factor: 17.367

3.  Human placental adenosine kinase. Kinetic mechanism and inhibition.

Authors:  T D Palella; C M Andres; I H Fox
Journal:  J Biol Chem       Date:  1980-06-10       Impact factor: 5.157

4.  The rate of transmethylation in mouse liver as measured by trapping S-adenosylhomocysteine.

Authors:  J L Hoffman
Journal:  Arch Biochem Biophys       Date:  1980-11       Impact factor: 4.013

5.  Purine catabolism in isolated rat hepatocytes. Influence of coformycin.

Authors:  G Van den Berghe; F Bontemps; H G Hers
Journal:  Biochem J       Date:  1980-06-15       Impact factor: 3.857

6.  Effect of NADH on hypoxanthine hydroxylation by native NAD+-dependent xanthine oxidoreductase of rat liver, and the possible biological role of this effect.

Authors:  Z W Kamiński; M M Jezewska
Journal:  Biochem J       Date:  1981-12-15       Impact factor: 3.857

7.  Binding of adenosine to intracellular S-adenosylhomocysteine hydrolase in isolated rat hepatocytes.

Authors:  P M Ueland; S Helland
Journal:  J Biol Chem       Date:  1983-01-25       Impact factor: 5.157

8.  The pathway of adenine nucleotide catabolism and its control in isolated rat hepatocytes subjected to anoxia.

Authors:  M F Vincent; G Van den Berghe; H G Hers
Journal:  Biochem J       Date:  1982-01-15       Impact factor: 3.857

9.  Evidence for a substrate cycle between AMP and adenosine in isolated hepatocytes.

Authors:  F Bontemps; G Van den Berghe; H G Hers
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

10.  Purification and some properties of cytosol 5'-nucleotidase from rat liver.

Authors:  R Itoh
Journal:  Biochim Biophys Acta       Date:  1981-02-13
View more
  15 in total

1.  Intense exercise induces the degradation of adenine nucleotide and purine nucleotide synthesis via de novo pathway in the rat liver.

Authors:  Toshio Mikami; Jun Kitagawa
Journal:  Eur J Appl Physiol       Date:  2005-12-21       Impact factor: 3.078

2.  Enzyme-mediated cytosine deamination by the bacterial methyltransferase M.MspI.

Authors:  J M Zingg; J C Shen; P A Jones
Journal:  Biochem J       Date:  1998-05-15       Impact factor: 3.857

3.  Brain somatic mutations in MTOR reveal translational dysregulations underlying intractable focal epilepsy.

Authors:  Jang Keun Kim; Jun Cho; Se Hoon Kim; Hoon-Chul Kang; Dong-Seok Kim; V Narry Kim; Jeong Ho Lee
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 14.808

4.  Neonatal hepatic steatosis by disruption of the adenosine kinase gene.

Authors:  Detlev Boison; Louis Scheurer; Valérie Zumsteg; Thomas Rülicke; Piotr Litynski; Brian Fowler; Sebastian Brandner; Hanns Mohler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

5.  Attenuation of ischemic liver injury by augmentation of endogenous adenosine.

Authors:  S Todo; Y Zhu; S Zhang; M B Jin; N Ishizaki; H Tanaka; V Subbotin; T E Starzl
Journal:  Transplantation       Date:  1997-01-27       Impact factor: 4.939

Review 6.  Adenosine kinase: exploitation for therapeutic gain.

Authors:  Detlev Boison
Journal:  Pharmacol Rev       Date:  2013-04-16       Impact factor: 25.468

7.  Regulatory processes interacting to maintain hepatic blood flow constancy: Vascular compliance, hepatic arterial buffer response, hepatorenal reflex, liver regeneration, escape from vasoconstriction.

Authors:  W Wayne Lautt
Journal:  Hepatol Res       Date:  2007-11       Impact factor: 4.288

8.  Phosphorylation of adenosine in anoxic hepatocytes by an exchange reaction catalysed by adenosine kinase.

Authors:  F Bontemps; M Mimouni; G Van den Berghe
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

9.  Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice.

Authors:  Tianfu Li; Gaoying Ren; Theresa Lusardi; Andrew Wilz; Jing Q Lan; Takuji Iwasato; Shigeyoshi Itohara; Roger P Simon; Detlev Boison
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

10.  Adenosine kinase is a new therapeutic target to prevent ischemic neuronal death.

Authors:  Detlev Boison; Hai-Ying Shen
Journal:  Open Drug Discov J       Date:  2010-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.